Diffuse Large B-Cell Lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, comprising approximately 25-30% of adult non-Hodgkin lymphomas in western countries and consists
Diffuse large B-cell lymphoma (DLBCL) Diffuse large B-cell lymphoma (DLBCL) is an aggressive type of non- Hodgkin lymphoma that develops from the B-cells in the lymphatic system ... Under the microscope, large malignant…
Objectives: Bone marrow assessment is a diagnostic challenge in staging diffuse large B-cell lymphoma (DLBCL). Diffuse bone marrow uptake (BMU) can be observed on FDG PET/CT performed
Anaplastic Diffuse Large B-Cell Lymphoma (A-DLBCL) is a mysterious and rare disease; its histopathological features have not been fully clarified today. This paper provides a case ... nodular or follicular germinating…
expression. In this review, we have discussed the various trials of Brentuximab Vedotin.in diffuse large B-cell lymphoma. Brentuximab Vedotin.is an ADC of monoclonal antibody conjugated with Monomethyl Auristatin…
Report Background: Intravascular large B-cell lymphoma (IVLBCL) is a rare type of non-Hodgkin’s lymphoma (NHL) characterized by the selective growth of neoplastic cells within blood vessel lamina ... symptoms and…
pancreas is usually of the non-Hodgkin’s or B-cell type with diffuse large B-cell lymphoma being the most common hystotype. We report an unusual case of secondary ... pancreatic, nodular involvement diagnosed by EUS-FNA…
report a case of diffuse large B-cell lymphoma involving the thigh skin and tongue in an 85-year-old woman. No systemic symptoms or other lesions were observed ... pancreas. To our knowledge, this is the first report of…
rituximab in combination with chemotherapy has substantially changed the outcome of patients with diffuse large B-cell lymphoma. This update will discuss the factors that improved our predictive capacity ... major…
revealed CD10-, CD20+++, Bcl-2+++, and ki67+ (>90%), thereby confirming the diagnosis of diffuse large B-cell lymphoma. Emergency physicians are always aware of great vessel diseases in cases ... mediastinal widening…
four patients with non-Hodgkin's lymphoma: • Diffuse large B cell lymphoma (DLBCL) • Follicular lymphoma • Marginal zone B cell lymphoma (MZL) or lymphoma of the lymphatic tissues associated with ... Hodgkin's. Most…
Diffuse large B-cell lymphoma (DLBCL) is an aggressive B-cell non-Hodgkin?s lymphoma (NHL) affecting patients of all ages with a wide range of clinical presentations. Even though
expression of several subtypes of glucose transporters (GLUT) and Ki-67 in diffuse large B-cell lymphoma (DLBCL) and natural killer (NK)/T-cell lymphoma (NKTCL). Cell lines were histologically
objectives of this study were to detect immunohistochemical subtypes of diffuse large B-cell lymphoma (DLBCL) of the head and neck, to compare the Hans, Choi, and Tally algorithms
improve understanding of the diagnosis, treatment, and prognosis of primary bone marrow (PBM) diffuse large B-cell lymphoma (DLBCL), a rare illness. We report a 56-year-old man with
Background: The cell of origin (COO) in diffuse large B-cell lymphoma (DLBCL) has prognostic importance. While the COO was originally classified into germinal center B-cell (GCB) or activated
subsequent results of autologous stem cell transplantation (ASCT) for relapsed or primary refractory diffuse large B-cell lymphoma (DLBCL). The random-effect model was used with the relative risk
extremely rare. We present 2 cases of patients with bilateral adrenal primary diffuse large B-cell lymphoma (PA-DLBCL) whose adrenal functions were normal. 2 patients were treated with unilateral
Diffuse large B-cell lymphoma is the largest subtype of non-Hodgkin’s lymphomas, and is characterized by frequent extranodal presentation. The most common extranodal locations of non-Hodgkin ... Report: This study has…
sign of metastasis. His histology showed high grade B-cell lymphoma likely diffuse large B-cell lymphoma in the ileum. He recovered well and was referred to oncology for ongoing ... management of his lymphoma…
positive diffuse Large B-cell lymphomas (DLBCL) are clonal proliferation of EBV+ B-cells occurring in patients who have no prior history of immunodeficiency or lymphoma. Its prevalence
CHOP. Addition of rituximab to the CHOP regimen improved outcomes for patients with diffuse large B-cell lymphoma [DLBCL]. Hence, we conducted a retrospective study comparing CHOP with R-CHOP ... Rituximab to CHOP…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.